A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5 — Andrés Gámez-García (2024) | RDL Network
A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5
Article 2024 en
Authors
AG
Andrés Gámez-García
ME
Maria Espinosa‐Alcantud
AB
Alberto Bueno-Costa
Abstract
1 min read
Abstract B lymphopoiesis is orchestrated by lineage-specific transcription factors. In B cell progenitors, lineage commitment is mediated by Pax5, which is commonly mutated in B cell acute lymphoblastic leukemia. Despite its essential role in immunity, the mechanisms regulating Pax5 function remain largely unknown. Here, we found that the NAD + -dependent enzyme SIRT7 coordinates B cell development through deacetylation of Pax5 at K198, which promotes Pax5 protein stability and transcriptional activity. Neither Pax5 K198 deacetylated nor acetylated mimics rescued B cell differentiation in Pax5 −/− pro-B cells, suggesting that B cell development requires Pax5 dynamic deacetylation. The Pax5 K198 deacetylation mimic restored lineage commitment in Pax5 −/− pro-B cells and B cell differentiation in Sirt7 −/− pro-B cells, suggesting the uncoupling of differentiation from lineage commitment. The SIRT7–Pax5 interplay was conserved in B cell acute lymphoblastic leukemia, where SIRT7 expression correlated with good prognosis. Our findings reveal a crucial mechanism for B lymphopoiesis and highlight the relevance of sirtuins in immune function.
Bruna Barneda‐Zahonero, Olga Collazo, Alba Azagra, Irene Fernández-Duran, Jordi Serra-Musach, Abul Bashar Mir Md. Khademul Islam, Nerea Vega‐García, Roberta Malatesta, Mireia Cámos, Antonio Gómez, Lidia Román-González, August Vidal, Núria López-Bigas, Alberto Villanueva, Manel Esteller, Maribel Parra
Kadriye Nehir Cosgun, Gauri Deb, Xin Yang, Gang Xiao, Teresa Sadras, Jae Woong Lee, Lai N. Chan, Kohei Kume, Lu Yang, Huimin Geng, John Chan, Joo Y. Song, Hassan Jumaa, Andrew G. Polson, Hans Clevers, Markus Müschen
Discussion(0)
No comments yet. Be the first to comment.